novo nordisk glp-1 weight loss Eli Lilly set to leapfrog in weight-loss drug race US employers still reluctant to

Give yourself 10 minutes once a week, and let the rest of the week run on autopilot

Michigan's largest health insurer, Blue Cross Blue Shield of Michigan, is stopping coverage for glucagon-like peptide-1 (GLP-1) drugs used for weight loss starting in January 2025

Researchers at the Lunenfeld-Tanenbaum Research Institute, part of Sinai Health, have discovered a gut-brain-immune network and posit a new gut-brain glucagon-like peptide 1 (GLP-1R) that controls inflammation across the body, a discovery which holds promise for understanding and treating metabolic diseases

Being on GLP1 can feel like a relief and a curveball at the same time

Understand Remedy Meds: how the weight loss program is structured, cost, compounded pathway, and alternatives

Unintentional weight loss means losing weight without trying